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Abstract
C25H17BrFN3S, triclinic, P1¯ (no. 2), a= 11.2926(6) Å,
b= 11.5832(4) Å, c= 16.9974(9) Å, α= 109.211(4)°,
β= 90.211(4)°, γ= 95.290(4))°, V = 2089.21(18) Å3, Z= 4,
Rgt(F)=0.0580, wRref(F2)=0.1797, T= 296 K.
CCDC no.: 1989338
The asymmetric unit of the title structure is shown in the
figure. Table 1 contains crystallographic data and Table 2 con-
tains the list of the atoms including atomic coordinates and
displacement parameters.
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Table 1: Data collection and handling.
Crystal: Yellow plate
Size: 0.31×0.23×0.05 mm
Wavelength: Mo Kα radiation (0.71073 Å)
µ: 2.10 mm−1
Diffractometer, scan mode: SuperNova, ω
θmax, completeness: 29.8°,>99%
N(hkl)measured, N(hkl)unique, Rint: 18184, 9828, 0.026
Criterion for Iobs, N(hkl)gt: Iobs > 2 σ(Iobs), 5689
N(param)refined: 559
Programs: CrysAlisPRO [1], SHELX [2, 3],
WinGX/ORTEP [4]
Source of material
The title compound was synthesized from reaction of 3-(4-
bromophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1H-pyrazole-1-
carbothioamide (0.76 g, 2.0 mmol) and 2-bromo-2,3-dihydro-
1H-inden-1-one (1.10 g, 2.0 mmol) in anhydrous ethanol
(20 mL) under reflux for 2 h. The solid obtainedwas collected
by filtration, washed with ethanol, dried, and recrystallized
from dimethylformamide to give yellow crystals in 75% yield
(Mp. 245–247 °C).
Experimental details
All hydrogen atoms were identified in difference Fourier syn-
theses. The methine, methylene and aromatic ring hydrogens
were idealized during refinement using options AFIX 13, AFIX
23 and AFIX 43 respectively in the SHELXL-2018 program [3].
The U iso values of the hydrogen atoms were set to 1.2Ueq(C).
Comment
Indeno[1,2-d]thiazoles act as A1 adenosine receptor agonist
allosteric enhancers [5] and anorectic agents [6]. Heterocycles
containing pyrazole and thiazole moieties are biologically
active and show some medicinal activities [7–9]. The most
common synthetic methods for pyrazoles involve a treatment
of 1,3-difunctional compounds with hydrazines [10], whereas
thiazoles are commonly synthesized through Hantzsch,
Gabriel, and Cook–Heilborn’s syntheses [11]. Recently, the
X-ray crystal structures of related compounds have been
reported [12–15].
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Table 2: Fractional atomic coordinates and isotropic or equivalent
isotropic displacement parameters (Å2).
Atom x y z Uiso*/Ueq
C1 0.7847(3) −0.9138(3) −0.0235(3) 0.0449(9)
C2 0.7956(4) −0.8662(3) 0.0605(3) 0.0496(10)
C3 0.8437(4) −0.9531(4) 0.0985(3) 0.0579(11)
H3A 0.788957 −0.972712 0.137200 0.070*
H3B 0.920423 −0.920470 0.126766 0.070*
C4 0.8542(3) −1.0631(3) 0.0213(3) 0.0520(10)
C5 0.8177(3) −1.0398(3) −0.0506(3) 0.0474(9)
C6 0.8937(4) −1.1753(4) 0.0138(4) 0.0643(13)
H6 0.919225 −1.191634 0.060814 0.077*
C7 0.8949(4) −1.2640(4) −0.0648(4) 0.0711(15)
H7 0.922093 −1.339470 −0.070144 0.085*
C8 0.8570(4) −1.2415(4) −0.1334(4) 0.0684(13)
H8 0.857739 −1.302330 −0.185239 0.082*
C9 0.8165(4) −1.1285(4) −0.1280(3) 0.0589(11)
H9 0.789733 −1.113843 −0.175317 0.071*
C10 0.7353(3) −0.7322(3) −0.0106(3) 0.0449(9)
C11 0.6999(3) −0.6294(3) −0.1168(2) 0.0426(9)
H11 0.651597 −0.700770 −0.154705 0.051*
C12 0.6363(3) −0.5129(3) −0.1024(3) 0.0450(9)
H12A 0.674895 −0.460110 −0.130728 0.054*
H12B 0.553341 −0.532903 −0.121040 0.054*
C13 0.6487(3) −0.4542(3) −0.0097(2) 0.0414(8)
C14 0.8228(3) −0.6187(3) −0.1503(2) 0.0397(8)
C15 0.9256(3) −0.6046(3) −0.1016(3) 0.0448(9)
H15 0.919675 −0.603527 −0.046835 0.054*
C16 1.0366(4) −0.5920(3) −0.1335(3) 0.0524(10)
H16 1.105346 −0.581839 −0.100666 0.063*
C17 1.0431(4) −0.5949(4) −0.2139(3) 0.0565(11)
C18 0.9436(4) −0.6092(4) −0.2647(3) 0.0587(11)
H18 0.950311 −0.611258 −0.319593 0.070*
C19 0.8335(4) −0.6205(4) −0.2313(3) 0.0515(10)
H19 0.765123 −0.629463 −0.264292 0.062*
C20 0.6190(3) −0.3308(3) 0.0363(3) 0.0414(8)
C21 0.5708(3) −0.2606(3) −0.0061(3) 0.0488(9)
H21 0.560032 −0.292225 −0.063754 0.059*
C22 0.5388(4) −0.1444(4) 0.0365(3) 0.0543(11)
H22 0.506645 −0.098061 0.007864 0.065*
C23 0.5551(4) −0.0989(3) 0.1210(3) 0.0527(10)
C24 0.6058(4) −0.1638(4) 0.1653(3) 0.0557(10)
H24 0.618604 −0.130090 0.222721 0.067*
C25 0.6370(4) −0.2798(4) 0.1224(3) 0.0513(10)
H25 0.670611 −0.324748 0.151575 0.062*
C26 0.7911(4) −0.6370(4) −0.4978(3) 0.0595(11)
C27 0.7786(4) −0.6799(4) −0.5812(3) 0.0616(12)
C28 0.8099(5) −0.5818(4) −0.6194(3) 0.0730(14)
H28A 0.743381 −0.571018 −0.651702 0.088*
H28B 0.878197 −0.599197 −0.654405 0.088*
C29 0.8386(4) −0.4718(4) −0.5418(3) 0.0660(13)
C30 0.8279(4) −0.5048(4) −0.4691(3) 0.0596(11)
C31 0.8733(5) −0.3507(5) −0.5342(4) 0.0815(17)
H31 0.881020 −0.327248 −0.581403 0.098*
C32 0.8962(5) −0.2651(5) −0.4559(4) 0.0879(18)
H32 0.920104 −0.183921 −0.451072 0.105*
C33 0.8846(5) −0.2968(5) −0.3847(4) 0.0892(17)
H33 0.899697 −0.237443 −0.332498 0.107*
Table 2 (continued)
Atom x y z Uiso*/Ueq
C34 0.8502(5) −0.4185(4) −0.3917(4) 0.0738(14)
H34 0.842377 −0.441041 −0.344131 0.089*
C35 0.7345(4) −0.8260(4) −0.5101(3) 0.0583(11)
C36 0.6952(4) −0.9366(4) −0.4054(3) 0.0540(10)
H36 0.649351 −0.871964 −0.370693 0.065*
C37 0.6235(4) −1.0623(4) −0.4234(3) 0.0584(11)
H37A 0.660165 −1.112115 −0.395987 0.070*
H37B 0.542251 −1.053572 −0.405905 0.070*
C38 0.6285(4) −1.1162(4) −0.5166(3) 0.0532(10)
C39 0.8161(4) −0.9272(3) −0.3643(3) 0.0472(9)
C40 0.8226(4) −0.9273(4) −0.2831(3) 0.0561(11)
H40 0.752743 −0.932860 −0.255177 0.067*
C41 0.9309(4) −0.9194(4) −0.2426(3) 0.0599(11)
H41 0.934775 −0.919487 −0.187980 0.072*
C42 1.0308(4) −0.9116(4) −0.2846(3) 0.0608(11)
C43 1.0302(4) −0.9117(4) −0.3645(3) 0.0626(12)
H43 1.101001 −0.906769 −0.391531 0.075*
C44 0.9214(4) −0.9192(4) −0.4045(3) 0.0535(10)
H44 0.918958 −0.918875 −0.459169 0.064*
C45 0.5863(4) −1.2433(4) −0.5670(3) 0.0522(10)
C46 0.5211(4) −1.3196(4) −0.5316(3) 0.0631(12)
H46 0.506257 −1.291512 −0.475032 0.076*
C47 0.4778(5) −1.4382(4) −0.5803(3) 0.0705(13)
H47 0.431153 −1.488225 −0.557087 0.085*
C48 0.5042(4) −1.4803(4) −0.6624(3) 0.0598(11)
C49 0.5717(5) −1.4096(4) −0.6979(3) 0.0724(14)
H49 0.590483 −1.440813 −0.753709 0.087*
C50 0.6126(5) −1.2908(4) −0.6507(3) 0.0677(13)
H50 0.658327 −1.241867 −0.675138 0.081*
N1 0.7501(3) −0.8388(3) −0.0660(2) 0.0454(8)
N2 0.7015(3) −0.6367(3) −0.0326(2) 0.0472(8)
N3 0.6834(3) −0.5267(3) 0.0282(2) 0.0428(7)
N4 0.7652(3) −0.7184(3) −0.4544(2) 0.0593(9)
N5 0.7018(4) −0.9287(3) −0.4898(2) 0.0659(11)
N6 0.6692(3) −1.0389(3) −0.5523(2) 0.0569(9)
Br1 0.51139(5) 0.06048(4) 0.18048(4) 0.0835(2)
Br2 0.44554(6) −1.64283(5) −0.72785(4) 0.0974(2)
S1 0.76099(10) −0.71559(9) 0.09420(7) 0.0530(3)
S2 0.73495(12) −0.83545(11) −0.61521(8) 0.0671(3)
F1 1.1517(2) −0.5866(3) −0.2468(2) 0.0849(9)
F2 1.1384(3) −0.8993(3) −0.2442(2) 0.0937(10)
The asymmetric unit of the title structure consists of
two independent molecules (see the figure). The molecule
comprises indenothiazolyl (A1[C1—C10,N1,S1] and A2[C26—
C35,N4,S2]), pyrazolyl (B1[C11—C13,N2,N3] and B2[C36—
C38,N5,N6]), bromophenyl (C1[C20—C25,Br1] and C2[C45—
C50,Br2]) and fluorophenyl (D1[C14—C19,F1] and D2[C39—
C44,F2]) ring systems. In both molecules, ring systems A, B
and C are almost coplanar with twist angles A1/B1= 6.63(15)°
and B1/C1= 7.48(18)° for one molecule and A2/B2= 11.13(21)°
and B2/C2= 14.35(20)° for the other molecule. The interpla-
nar angle between the fluorophenyl and pyrazolyl rings are
Alotaibi et al.: C25H17BrFN3S | 899
B1/D1= 71.64(13)° and B2/D2= 66.35(15)°. In the crystal, a
number of rings are involved in π· · · π interactions. The rings
of the fluorophenyl groups of one typeofmolecule are parallel
with a D2· · ·D2 centroid separation of 3.62 Å. The indenoth-
iazolyl groups are also parallel with centroid separations
A1· · ·A1= 4.18 Å and A2· · ·A2= 4.21 Å. The indenothiazolyl
group of one molecule and the bromophenyl group of the
other are also parallel with A1· · ·C1 a centroid separation
of 4.15 Å. Two molecules of one type are linked by a pair of
C16—H16· · ·N3 contacts.
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